Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

ValiRx (VAL) Share Price

Price 0.50p on 18-04-2025 at 04:45:13
Change 0.00p 0%
Buy 0.55p
Sell 0.45p
Buy / Sell VAL Shares
Last Trade: Buy 90,649.00 at 0.524p
Day's Volume: 0
Last Close: 0.50p
Open: 0.00p
ISIN: GB00BLH13C52
Day's Range 0.00p - 0.00p
52wk Range: 0.39p - 4.35p
Market Capitalisation: £2m
VWAP: 0.00p
Shares in Issue: 374m

ValiRx (VAL) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 90,649 0.524p Ordinary
15:17:39 - 17-Apr-25
Buy* 4,193 0.525p Ordinary
13:42:34 - 17-Apr-25
Sell* 15,463 0.475p Ordinary
13:28:14 - 17-Apr-25
Buy* 100,000 0.525p Ordinary
10:10:33 - 17-Apr-25
Buy* 23,000 0.527p Ordinary
09:27:28 - 17-Apr-25
Sell* 396,957 0.4725p Ordinary
09:21:00 - 17-Apr-25
Sell* 800 0.475p Ordinary
08:04:59 - 17-Apr-25
Buy* 11,000 0.527p Ordinary
16:29:07 - 16-Apr-25
Sell* 3,940 0.475p Ordinary
16:11:06 - 16-Apr-25
Buy* 2,666 0.525p Ordinary
16:08:32 - 16-Apr-25
See more ValiRx trades

ValiRx (VAL) Share Price History

Time period:
to
Date Open High Low Close Volume
18th Apr 2025 (Fri) 0.50 0.50 0.50 0.50 0
17th Apr 2025 (Thu) 0.50 0.50 0.50 0.50 640,582
16th Apr 2025 (Wed) 0.50 0.50 0.50 0.50 96,951
15th Apr 2025 (Tue) 0.50 0.50 0.50 0.50 291,099
14th Apr 2025 (Mon) 0.525 0.525 0.50 0.50 1,169,276
11th Apr 2025 (Fri) 0.525 0.525 0.525 0.525 594,009
10th Apr 2025 (Thu) 0.525 0.525 0.525 0.525 290,786
9th Apr 2025 (Wed) 0.475 0.525 0.475 0.525 5,058,309
8th Apr 2025 (Tue) 0.425 0.475 0.425 0.475 7,510,316
7th Apr 2025 (Mon) 0.415 0.425 0.39 0.425 23,277,249
4th Apr 2025 (Fri) 0.45 0.45 0.40 0.415 4,021,197
3rd Apr 2025 (Thu) 0.45 0.45 0.425 0.45 7,477,243
2nd Apr 2025 (Wed) 0.50 0.50 0.475 0.475 296,018
1st Apr 2025 (Tue) 0.50 0.50 0.50 0.50 168,229
31st Mar 2025 (Mon) 0.50 0.50 0.50 0.50 428,712
28th Mar 2025 (Fri) 0.525 0.525 0.475 0.50 8,226,680
27th Mar 2025 (Thu) 0.575 0.575 0.525 0.525 2,136,314
26th Mar 2025 (Wed) 0.575 0.575 0.575 0.575 464,273
25th Mar 2025 (Tue) 0.575 0.575 0.575 0.575 1,190,908
24th Mar 2025 (Mon) 0.60 0.60 0.575 0.575 1,956,406
21st Mar 2025 (Fri) 0.60 0.60 0.60 0.60 764,784
20th Mar 2025 (Thu) 0.60 0.60 0.60 0.60 358,161
19th Mar 2025 (Wed) 0.60 0.60 0.60 0.60 438,093
See more ValiRx price history

ValiRx (VAL) Regulatory News

Date Source Headline
3rd Apr 2025 7:00 am RNS Termination of Letter of Intent with TheoremRx
27th Mar 2025 7:00 am RNS Directorate Changes and new Advisory Board
21st Mar 2025 11:07 am RNS Director Disclosure Update
24th Feb 2025 7:00 am RNS Conclusion of Evaluation Project
3rd Feb 2025 7:00 am RNS Inaphaea Evaluation and Commercial Use Agreement
30th Jan 2025 7:00 am RNS Extension of Evaluation Agreement
29th Jan 2025 7:00 am RNS New Evaluation and Option Agreement
15th Jan 2025 12:47 pm RNS Holding(s) in Company
15th Jan 2025 11:29 am RNS Holding(s) in Company
14th Jan 2025 7:00 am RNS Holding(s) in Company
See more ValiRx regulatory news

ValiRx (VAL) Share News

TRADING UPDATES: Strategic Minerals sales up; 4Global wins contract

4th Apr 2025 18:29

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

LONDON MARKET OPEN: Europe, Asia down as investors digest US tariffs

3rd Apr 2025 09:01

(Alliance News) - London stocks slumped alongside Asian and European peers at Thursday's market open, as US tariff announcements and the prospect of trade war throws the global market into turmoil. Read More

ValiRx shares fall as ends collaboration with Imperial College London

24th Feb 2025 16:20

(Alliance News) - ValiRx PLC on Monday said it has decided to return the Dual Kinase project to Imperial College London for further development, and will have no further financial commitment to the programme. Read More

AIM WINNERS & LOSERS: Strong 2024 for Quadrise and Rosebank

31st Dec 2024 10:58

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday. Read More

ValiRx extends TheoremRx exclusivity period to final May 31 deadline

31st Dec 2024 10:58

(Alliance News) - ValiRx PLC on Tuesday said it has extended the exclusivity period for a proposed sub-license agreement with TheoremRx Inc for its VAL201 therapeutic candidate, setting a final deadline of May 31. Read More

See more ValiRx news
FTSE 100 Latest
Value8,275.66
Change0.00

Login to your account

Forgot Password?

Not Registered